Granulocyte–macrophage CSF (GM-CSF) drives microglia-dependent glioma invasion in vitro, while mRNA expression of its gene CSF-2 has been inversely associated with patient survival in GBM [118]. The gene discussed is CSF2; the disease is glioma.